Krane Funds Advisors’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,035
Closed -$350K 103
2023
Q4
$350K Hold
20,035
0.01% 82
2023
Q3
$356K Buy
20,035
+2,087
+12% +$37.2K 0.01% 89
2023
Q2
$323K Hold
17,948
0.02% 86
2023
Q1
$384K Hold
17,948
0.02% 80
2022
Q4
$384K Sell
17,948
-2,937
-14% -$57.6K 0.02% 93
2022
Q3
$370K Sell
20,885
-833
-4% -$17.4K 0.02% 98
2022
Q2
$508K Sell
21,718
-8,188
-27% -$172K 0.02% 77
2022
Q1
$697K Buy
+29,906
New +$734K 0.03% 124
2019
Q2
Sell
-40,300
Closed -$893K 221
2019
Q1
$893K Sell
40,300
-186,700
-82% -$3.7M 0.05% 52
2018
Q4
$3.92K Buy
227,000
+9,427
+4% +$188K 0.23% 34
2018
Q3
$5.74M Buy
217,573
+188,267
+642% +$4.55M 0.45% 30
2018
Q2
$791K Buy
29,306
+5,306
+22% +$149K 0.07% 47
2018
Q1
$654K Buy
+24,000
New +$606K 0.05% 43

Other funds holding KURE

Krane Funds Advisors's KURE Position: Q1 2024 in Review

Krane Funds Advisors sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q1 2024, closing a stake of 20,035 shares — an estimated $350K sold.

Krane Funds Advisors first reported a position in KURE in Q1 2018 and held it in 13 quarters. The position peaked at $5.74M in Q3 2018. 14 funds tracked by Wall St. Rank hold KURE as of Q1 2024.

  • Krane Funds Advisors reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q1 2024 after selling out during the quarter.
  • Krane Funds Advisors sold 20,035 KraneShares MSCI All China Health Care Index ETF shares in Q1 2024, an estimated $350K.
  • Krane Funds Advisors first reported a position in KraneShares MSCI All China Health Care Index ETF in Q1 2018 and held it in 13 quarters.
  • Krane Funds Advisors's KraneShares MSCI All China Health Care Index ETF position peaked at $5.74M in Q3 2018.
  • 14 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q1 2024.

Based on Krane Funds Advisors's 13F filing for Q1 2024, filed 16 Apr 2024.